1. American Psychiatric Association. Treatment of patients with schizophrenia, second edition. Recommendations for patients with schizophrenia. Arlington, VA: American Psychiatric Publishing, Inc; 2004.
2. Stahl S. Essential psychopharmacology. Cambridge, United Kingdom: Cambridge University Press; 1999.
3. Hardman J, Limbird L, Molinoff P. Goodman & Gilman’s pharmacological basis of therapeutics. New York, NY: McGraw-Hill; 1996.
4. Flanagan RJ, Ball RY. Gastrointestinal hypomotility: an under-recognized life-threatening adverse effect of clozapine. Forensic Sci Int. 2011;206(1-3):e31-36.
5. Palmer SE, McLean RM, Ellis PM, et al. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry. 2008;69(5):759-768.
6. Claghorn J, Honigfeld G, Abuzzahab F, Sr, et al. The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol. 1987;7:337-384.
7. Perrott J. Serious gastrointestinal adverse effects of clozapine. Psychopharmacology Newsletter. 2009;1-5.
8. Pare J, Riffand P, Baurdeix I. The clozapine in France. Information Psychiatric. 1993;4:389-397.
9. Levin TT, Barrett J, Mendelowitz A. Death from clozapine-induced constipation: case report and literature review. Psychosomatics. 2002;43:71-73.
10. Centorrino F, Baldessarini RJ, Frankenburg FR, et al. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry. 1996;153(6):820-822.
11. Sproule BA, Naranjo CA, Brenmer KE, et al. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence. Clin Pharmacokinet. 1997;33(6):454-471.
12. Urichuk L, Prior TI, Dursun S, et al. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Curr Drug Metab. 2008;9(5):410-418.
13. Perry P, Miller DD, Arndt SV, et al. Clozapine and norclozapine plasma concentrations and clinical responses of treatment-refractory schizophrenic patients. Am J Psychiatry. 1991;148:231-235.
14. Freudenreich O. Clozapine drug levels guide dosing. Current Psychiatry. 2009;8(3):78.-
15. Pelizza L, De Luca P, La Pesa M, et al. Clozapine-induced intestinal occlusion: a serious side effect. Acta Biomed. 2007;78:144-148.
16. Hayes G, Gibler B. Clozapine-induced constipation. Am J Psychiatry. 1995;152:298.-
17. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(suppl 1):S1-4.
18. Townsend G, Curtis D. Case report: rapidly fatal bowel ischaemia on clozapine treatment. BMC Psychiatry. 2006;6:43.-
